SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001125345-20-000155
Filing Date
2020-11-30
Accepted
2020-11-30 16:33:19
Documents
17
Period of Report
2020-11-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mgnx-20201125.htm   iXBRL 8-K 39793
2 EX-99.1 eversanapressrelease.htm EX-99.1 17576
8 image1.jpg GRAPHIC 9491
9 image2.jpg GRAPHIC 6347
  Complete submission text file 0001125345-20-000155.txt   227067

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20201125.xsd EX-101.SCH 2420
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgnx-20201125_cal.xml EX-101.CAL 708
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgnx-20201125_def.xml EX-101.DEF 1641
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20201125_lab.xml EX-101.LAB 23970
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20201125_pre.xml EX-101.PRE 12644
10 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20201125_htm.xml XML 10770
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36112 | Film No.: 201358472
SIC: 2834 Pharmaceutical Preparations